News
- Author:
- Sara Freeman
Publish date: February 21, 2025
The more recently people had been treated with B cell–depleting therapy the lower their level of immunogenicity.
News
- Author:
- Sara Freeman
Publish date: November 12, 2024
The analysis looked at treatment with the upadacitinib and abrocitinib (Cibinqo), both approved for treating AD in t...
News
- Author:
- Sara Freeman
Publish date: November 12, 2024
Delgocitinib cream, currently under FDA review for chronic hand eczema, was recently approved in Europe for treating adults with moderate to severe...
News
- Author:
- Sara Freeman
Publish date: October 31, 2024
Greater improvement in patient-reported hip pain and function at 6 months was achieved with total hip replacement than with resistance training in ...
News
- Author:
- Sara Freeman
Publish date: October 21, 2024
The product is a "new potent melanogenesis inhibitor that exhibits a unique mode of action while preserving melanocyte integrity," said Mukta Sachd...
News
- Author:
- Sara Freeman
Publish date: October 3, 2024
"Efforts are needed to make home and office phototherapy more available to patients," the lead author said.
News
- Author:
- Sara Freeman
Publish date: August 5, 2024
Positive results were reported from the DAHLIAS study of nipocalimab, the TWINSS study of iscalimab, and a phase 1 trial of tibulizumab, but it was...
News
- Author:
- Sara Freeman
Publish date: August 2, 2024
Data presented at EULAR 2024 suggest that there are positive times ahead for the treatment of systemic lupus erythematosus, with experts encouraged...
News
- Author:
- Sara Freeman
Publish date: July 2, 2024
Data from two studies corroborated what was already known about axial psoriatic arthritis rather than help define or differentiate it further from ...
News
- Author:
- Sara Freeman
Publish date: June 28, 2024
Patient-initiated care with or without remote monitoring for spondyloarthritis has been shown to work just as well as usual face-to-face care in tw...
News
- Author:
- Sara Freeman
Publish date: June 20, 2024
The primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce enthesitis more than placebo, as might have been exp...
News
- Author:
- Sara Freeman
Publish date: June 20, 2024
SHR0302 (ivarmacitinib) is highly selective for JAK 1 and the first JAK inhibitor to be originally developed and now tested in a phase 3 RA clinica...
News
- Author:
- Sara Freeman
Publish date: June 14, 2024
Results from the SELECT-GCA study showed that upadacitinib (Rinvoq) induced significant and sustained remission in people with new-onset or relapsi...
News
- Author:
- Sara Freeman
Publish date: June 11, 2024
Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in V...
News
- Author:
- Sara Freeman
Publish date: May 15, 2024
Evidence mounts that the anterior cruciate ligament may heal without surgery, but the long-term outcomes are only beginning to be evaluated.
